CoLink Vallux Active Bunion Launches Reports In2Bones Global

Multi-directional, No Fusion Correction Speeds and Simplifies Bunion Surgeries

CoLink Vallux Active Bunion has been launched by In2Bones Global, Inc. It is a new, minimally invasive, joint-sparing correction technique for moderate to severe bunions.

The Active Bunion implant and guided translational osteotomy technique improve on traditional open fixation approaches as well as newer bunion surgeries by providing surgeons with a simpler, faster procedure that doesn’t violate the joint or require a 1st Tarsometatarsal joint fusion.

The implant consists of a zero-prominence CoLink Vallux™ plate and a choice of non-locking and variable angle locking screws for enhanced angular stability, together with a full instrument set.

Using this new, minimally invasive procedure, surgeons can correct joint alignment in multiple dimensions while avoiding any restriction of the joint space and not fusing the joint at the midfoot. The result is total range of motion preservation and superior cosmesis via a much smaller incision of 1-2 cm, compared with the larger incision required for Chevron osteotomy (5-7 cm).

For the patient, the Active Bunion’s smaller incision and technique as a whole reduces internal scarring compared with other bunion corrections, decreasing the typical postoperative stiffness, pain, and potential for wound complications.

“Patients prefer the smallest possible incision, and they do not want a fused joint unless absolutely necessary,” explains Jon Simon, Executvie Vice President of Commerical at In2Bones. “The CoLink Vallux Active Bunion fulfills both of these patient demands.”

An Evolved Surgery with More Surgeon and Patient Benefits

With greater simplicity comes shorter OR time. The Active Bunion procedure can typically be completed in about 20 minutes, compared to 40-60 minutes plus for other more invasive and complex corrections. Recovery can also be shorter than traditional bunion surgeries. With no joint violation, which preserves the total range of motion, patients may return to weight-bearing activity sooner, with less physical therapy.

The Active Bunion’s evolved technique, technology, and fixation solution is intended to address over 90 percent of bunion cases. Compare it to other established hallux valgus procedures:

Lapidus – Unlike this end-stage procedure, the Active Bunion’s simpler, quicker guided implant technique cuts down on multiple surgical steps, thereby decreasing OR time. It spares the midfoot joint from fusion, with early weight-bearing, improved cosmesis, and fewer overall complications.

Percutaneous Screw Fixation – Compared to the blind resection and steep learning curve required for the Burr osteotomy, the Active Bunion procedure is reproducible and straightforward. The guided osteotomy reduces the risk of shortening or necrosis.

IM Blade Plates – Eliminating multiple surgical steps common to this technique, the Active Bunion procedure allows surgeons to dictate placement while the implant provides greater strength and stability through two distal and proximal screws instead of the customary single screw.

Like all other products in In2Bones’ extensive platform of single-use implants for the hand and foot, the CoLink Vallux™ Active Bunion system is packaged sterile for traceability and patient safety.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”